Dr. Todd Demmy, MD

Dr. Demmy practices at Roswell Park Cancer Institute in Los Angeles, California.

Dr. Demmy's NPI, 1720084122, was assigned on June 22, 2005. Dr. Demmy graduated from Sidney Kimmel Medical College in 1983. Dr. Demmy holds New York license 225983.

Dr. Demmy's primary practice is Roswell Park Cancer Institute, at 344 S Hauser Blvd, Los Angeles, CA 90036 in Los Angeles County. The practice phone is (716) 845-2300.

Dr. Demmy's primary practice is Roswell Park Cancer Institute in Los Angeles, California. Dr. Demmy is also affiliated with Roswell Park Comprehensive Cancer Center. The medical group on file is Kaleida Health. Dmand AI also links Dr. Demmy to 1 more home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Demmy practices, 2 sites in all. Vendor and product names are available with a free account.

Thoracic surgery (cardiothoracic vascular surgery) is Dr. Demmy's primary specialty in the NPI Registry, under taxonomy code 208G00000X. Dr. Demmy is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Demmy's licenses on file in 5 states: New York, New Jersey, Missouri, Pennsylvania and Texas.

Dmand AI lists esophagus, stomach, or upper small intestine surgery and lung resection among the conditions Dr. Demmy treats.

CMS data shows 14 Medicare services from Dr. Demmy across 1 procedure code in 2024, all of them office visits, for 60 Medicare patients. Medicare paid $645 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 60 Medicare patients who saw Dr. Demmy in 2024. The largest group is 65 to 74, with 25 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 1.82, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Demmy's median patient age at 72, with 57% women.

In 2023, Dr. Demmy wrote 13 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $41 in total drug cost.

Dr. Demmy accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 61 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Demmy, more than 67% of the clinicians it reports for that procedure.

Dmand AI links 160 papers to Dr. Demmy, published from 2004 to 2025. 2017 was the busiest year, with 8. The most frequent topics are Lung Neoplasms, Pneumonectomy and Carcinoma, Non-Small-Cell Lung. Dr. Demmy has published most often in Ann Thorac Surg. Dr. Demmy's most frequent co-authors are Mark W. Hennon, MD, Chukwumere E. Nwogu, MD and Elisabeth U. Dexter, MD.

Dmand AI links Dr. Demmy to 8 clinical trials, 3 of them phase 2 studies. 2 are still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung, Adenocarcinoma of Lung and Bone Neoplasms. Roswell Park Cancer Institute sponsors the most, 6.

CMS Open Payments shows 72 general payments to Dr. Demmy from 13 drug and device companies from 2016 to 2024. Consulting fees make up the largest share, 50% of the total. Covidien LP paid the most, $34,220.

Dmand AI lists 4 awards for Dr. Demmy, most recently America's Top Doctors in 2014.

Dr. Demmy graduated from Sidney Kimmel Medical College in 1983. Dr. Demmy is a member of AOA, AATS, ACCP, ACS, AMA and ASCO.

Dr. Demmy is in network with 11 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.